Inozyme Pharma logo

Inozyme Pharma

INZYNASDAQ

Inozyme Pharma is a biotechnology company in the healthcare sector on NASDAQ, led by Sanjay S. Subramanian, with a market cap of $257.3M.

Chief Executive OfficerSanjay S. Subramanian
Market Cap$257.3M
Biotechnology
Healthcare
Employees59.0
Country
United States of America

Overview

Overview of institutional ownership in INZY as of Q3 2025 with a market cap of $257.3M

All Institutions

Institutions
0
Value Held
-
Shares Held
-
Avg Position
-
Median Position
-

Hedge Funds

Hedge Funds
0
Value Held
-
Shares Held
-
Avg Position
-
Median Position
-

Ownership Breakdown

Institutional (non-HF): -Hedge Funds: -Retail & Other: 100.00%Retail & Other
Institutional (non-HF)
-
-
Hedge Funds
-
-
Retail & Other
100.0%
$257.3M

Based on market cap of $257.3M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in INZY as of Q3 2025

InstitutionPosition Value
Groupe la Francaise logo
Groupe la Francaise
Fund of Funds
-
0.00% of portfolio
TWO SIGMA ADVISERS, LLC logo
TWO SIGMA ADVISERS, LLC
Hedge FundMulti-Strategy
-
0.00% of portfolio
-
0.00% of portfolio
B
Beryl Capital Management LLC
Hedge FundEvent Driven
-
0.00% of portfolio
-
0.00% of portfolio
-
0.00% of portfolio
-
0.00% of portfolio
Hudson Bay Capital Management LP logo
Hudson Bay Capital Management LP
Hedge FundMulti-Strategy
-
0.00% of portfolio
-
0.00% of portfolio
-
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for INZY in Q3 2025

Traded
$202.2M
Buyers
0
Sellers
87
Total Bought
+-
Total Sold
$202.2M
Avg Position
-

Biggest Buyers

InstitutionNet Bought
No buyers found

Biggest Sellers

InstitutionNet Sold
B
Beryl Capital Management LLC
Hedge FundEvent Driven
$25.3M
6.3M shares
$18.0M
4.5M shares
GLAZER CAPITAL, LLC logo
GLAZER CAPITAL, LLC
Hedge FundMulti-Strategy
$17.3M
4.3M shares
S
Sofinnova Ventures Inc
Venture Capital
$17.1M
4.3M shares
$12.8M
3.2M shares
Trium Capital LLP logo
Trium Capital LLP
Hedge FundMulti-Strategy
$12.7M
3.2M shares
B
BlackRock, Inc.
Institution
$10.7M
2.7M shares
$10.0M
2.5M shares
$9.8M
2.4M shares
ALPINE ASSOCIATES MANAGEMENT INC. logo
ALPINE ASSOCIATES MANAGEMENT INC.
Hedge FundMerger Arb
$8.8M
2.2M shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited INZY in Q3 2025

New Positions
0
New Value
-
Exited Positions
87
Exited Value
$202.2M

New Positions

InstitutionPosition Value
No new positions found

Exited Positions

InstitutionPrevious Position
B
Beryl Capital Management LLC
Hedge FundEvent Driven
$25.3M
6.3M shares
$18.0M
4.5M shares
GLAZER CAPITAL, LLC logo
GLAZER CAPITAL, LLC
Hedge FundMulti-Strategy
$17.3M
4.3M shares
S
Sofinnova Ventures Inc
Venture Capital
$17.1M
4.3M shares
$12.8M
3.2M shares
Trium Capital LLP logo
Trium Capital LLP
Hedge FundMulti-Strategy
$12.7M
3.2M shares
B
BlackRock, Inc.
Institution
$10.7M
2.7M shares
$10.0M
2.5M shares
$9.8M
2.4M shares
ALPINE ASSOCIATES MANAGEMENT INC. logo
ALPINE ASSOCIATES MANAGEMENT INC.
Hedge FundMerger Arb
$8.8M
2.2M shares

Options Activity

Institutions with the largest Call and Put options positions in INZY as of Q3 2025

Call Positions
2
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
-
- contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
-
- contracts

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with INZY as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
Groupe la Francaise logo
Groupe la Francaise
Fund of Funds
0.00%
-
TWO SIGMA ADVISERS, LLC logo
TWO SIGMA ADVISERS, LLC
Hedge FundMulti-Strategy
0.00%
-
0.00%
-
B
Beryl Capital Management LLC
Hedge FundEvent Driven
0.00%
-
0.00%
-
0.00%
-
0.00%
-
Hudson Bay Capital Management LP logo
Hudson Bay Capital Management LP
Hedge FundMulti-Strategy
0.00%
-
0.00%
-
0.00%
-

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.